Literature DB >> 16952102

Sarcomatoid carcinoma and orbital apex syndrome.

L M Sadaba1, A García-Layana, P J Garcia-Gomez, A Salinas-Alaman.   

Abstract

PURPOSE: To report a case of sarcomatoid carcinoma and orbital apex syndrome in a previously healthy adult.
METHODS: A previously healthy 45-year-old man presented with exophthalmos of the left eye and a mass visible through his left nostril. A biopsy was performed and immunohistochemistry was used to confirm the diagnosis of the tumor. The patient was treated with chemotherapy and radiotherapy.
RESULTS: After treatment, we observed a substantial reduction in the size of the mass, but side effects of treatment developed. The visual acuity of the left eye was no light perception. Eight months later, the patient presented with bone and liver metastases, and he died 4 months later.
CONCLUSIONS: Sarcomatoid carcinoma is an aggressive tumor that can produce compressive symptoms with very poor visual and survival prognoses. A cranio-orbital computed tomography scan should be performed when patients present with symptoms of conjunctivitis and orbital apex syndrome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16952102     DOI: 10.1177/112067210601600417

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  3 in total

Review 1.  Carcinosarcoma of the orbit: report of two cases and review of the literature.

Authors:  Sasapin G Prakalapakorn; C Robert Bernardino; Paul L Auclair; Hans E Grossniklaus
Journal:  Ophthalmology       Date:  2008-06-17       Impact factor: 12.079

2.  Spindle Cell Carcinoma of Nasal Cavity- A Case Report.

Authors:  Priyank Mistry; Abhishek Mittal; Tapan Nagpal
Journal:  J Clin Diagn Res       Date:  2016-04-01

3.  Sinonasal spindle cell carcinoma presenting with bilateral visual loss: A case report and review of the literature.

Authors:  Tsung-Wei Liu; Shih-Han Hung; Po-Yueh Chen
Journal:  Oncol Lett       Date:  2016-05-25       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.